Skip to main content
# Title Department Research Year
351 Preclinical study of the pharmacokinetics of p75ECD-Fc, a novel human recombinant protein for treatment of Alzheimer’s disease, in Sprague Dawley rats Department of Pharmacology 2020
352 Combining acetyl salicylic acid and rofecoxib into novel oral tablets normalize platelet function with potential higher tolerability in patients with cardiovascular disorders Department of Pharmaceutical Analytical Chemistry 2020
353 Latanoprost niosomes as a sustained release ocular delivery system for the
management of glaucoma
Department of Pharmaceutics 2020
354 Modulation of rifampicin-induced hepatotoxicity using poly(lactic-co-glycolic acid) nanoparticles: a study on rat and cell culture models Department of Pharmaceutics 2020
355 Design and Synthesis of Novel Isatin-Based derivatives Targeting Cell Cycle Checkpoint Pathways as Potential Anticancer Agents Department of Medicinal Chemistry 2020
356 Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations Department of Clinical Pharmacy 2020
357 Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids Department of Pharmaceutical Organic Chemistry 2020
358 Development of Near-Infrared Fluorescent Probes with Large Stokes Shifts for Non-Invasive Imaging of Tumor Hypoxia Department of Pharmaceutical Organic Chemistry 2020
359 A Review on: Analysis of The First Oral, Direct Factor Xa Inhibitor; Rivaroxaban Department of Pharmaceutical Analytical Chemistry 2020
360 Effect of stevia aqueous extract on the antidiabetic activity of saxagliptin in diabetic rats 2020